[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]  Ozmosi [@OzmosiHealth](/creator/twitter/OzmosiHealth) on x 2635 followers Created: 2025-07-17 12:32:29 UTC $KROS Keros Therapeutics initiates Phase X RENEW Clinical Trial of Elritercept with first patient dosing announced. More Info: $XBI $IBB $XPH $PPH  XXX engagements  **Related Topics** [$pph](/topic/$pph) [$xph](/topic/$xph) [$ibb](/topic/$ibb) [$xbi](/topic/$xbi) [more info](/topic/more-info) [$kros](/topic/$kros) [Post Link](https://x.com/OzmosiHealth/status/1945823922462900330)
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Ozmosi @OzmosiHealth on x 2635 followers
Created: 2025-07-17 12:32:29 UTC
$KROS Keros Therapeutics initiates Phase X RENEW Clinical Trial of Elritercept with first patient dosing announced.
More Info: $XBI $IBB $XPH $PPH
XXX engagements
/post/tweet::1945823922462900330